Experience
Accord Healthcare Limited & Ors v. The Regents of the University of California & Astellas Pharma Europe Ltd.*
Accord Healthcare Limited & Ors
The Regents of the University of California & Astellas Pharma Europe Ltd.
Successfully represented Astellas Pharma and The Regents of the University of California in defeating validity challenges brought by multiple generic companies on patents covering the blockbuster medicine Xtandi® (enzalutamide) for treating prostate cancer. This matter was named a 2026 “Europe Cross-border Patent Litigation Team of the Year” at Managing IP’s EMEA Awards.
Accord Healthcare Limited & Ors v. The Regents of the University of California & Astellas Pharma Europe Ltd., [2024] EWHC 2524 (Pat), Claim numbers: HP-2022-000030, HP-2023-000002, and HP-2023-000011, Patents Court
Accord Healthcare Limited & Ors v. The Regents of the University of California & Astellas Pharma Europe Ltd., [2025] EWCA Civ 936, Appeal numbers: CA-2024-002655/002675/002676, Court of Appeal
Related Professionals
- Jin Ooi
- Partner
- London
- +44 20 7864 2821
Related Practices
Related Industries
*Matter handled prior to joining Finnegan.